GQG Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17M Sell
97,640
-67,065
-41% -$3M 0.01% 83
2026
Q1
$7.94M Buy
164,705
+43,759
+36% +$2.04M 0.01% 59
2025
Q4
$5.86M Buy
120,946
+35,196
+41% +$1.74M 0.01% 60
2025
Q3
$4.05M Buy
+85,750
New +$4.14M 0.01% 70
2025
Q2
Sell
-3,647
Closed -$202K 104
2025
Q1
$202K Buy
+3,647
New +$197K ﹤0.01% 86

Other funds holding SNY

GQG Partners's SNY Position: Q2 2026 in Review

GQG Partners reduced its Sanofi (SNY) stake by 41% in Q2 2026, selling an estimated $3M and leaving 97,640 shares worth $4.17M. The position accounts for 0.01% of the portfolio, ranked #83.

GQG Partners first reported a position in SNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $7.94M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • GQG Partners held 97,640 shares of Sanofi worth $4.17M as of Q2 2026.
  • GQG Partners sold 67,065 Sanofi shares in Q2 2026, an estimated $3M.
  • Sanofi made up 0.01% of GQG Partners's portfolio in Q2 2026, its #83 holding.
  • GQG Partners first reported a position in Sanofi in Q1 2025 and has held it in 5 quarters since.
  • GQG Partners's Sanofi position peaked at $7.94M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on GQG Partners's 13F filing for Q2 2026, filed 12 Aug 2026.